Sale

Scar Treatment Market

Scar Treatment Market Size, Share, Trends, Growth, Analysis: By Scar Type: Atrophic Scars, Hypertrophic and Keloid Scars, Contracture Scars, Stretch Marks; By Product: Topical Products, Laser Products, Injectable, Others; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics; Supplier Landscape, 2024-2032

Scar Treatment Market Outlook

The scar treatment market size was valued at USD 20.32 billion in 2023, driven by the rising prevalence of demand for cosmetic procedures across the 8 major markets. The market is expected to grow at a CAGR of 11% during the forecast period of 2024-2032, with the values likely to rise from USD 22.50 billion in 2024 to USD 51.39 billion by 2032.

 

Scar Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Scar Treatment Market Overview

Scar treatment includes a range of techniques and products used to reduce, mask, or completely remove scars on the skin. Scars may be caused by injuries, surgeries, burns, acne, and other skin disorders. It develops as a result of the body's natural healing process. Topical creams, gels, silicone sheets, laser therapy, surgery, and injections are amongst the common treatments for treating scars.

 

The scar treatment market growth is driven by individuals becoming more self-conscious about their appearance. This has resulted in increased scar removal and reduction treatments. Consequently, resulting in increased incidence in approvals from regulatory authorities. For instance, in August 2023, FDA approved Sofwave Medical Ltd.'s Precise SUPERB Applicator to treat acne scars, expanding its list of approved uses beyond cellulite. After three sessions, a multicenter clinical research spread across multiple US locations showed a notable improvement in the appearance of acne scars. Most patients expressed relief and great pleasure with their outcomes. There were no significant adverse events in the research, which showed a positive safety profile.

 

To meet the rising scar treatment market demand, mergers and collaborations are witnessing a significant surge. In June 2023, International Medical Lasers (IML) partnered with DEKA Trio to offer laser accessories, including a scanner for CO2 laser-assisted scar reconstruction. The terms of agreement also focused on an FDA approved novel scanner for surgical scar correction By collaborating with global medical providers and manufacturers, new-age and technology driven companies are bringing cutting-edge medical technology to the markets, further driving its growth.

 

The scar treatment market share for products and services continues to expand, driven by rising application in the realm of medical aesthetics for non-surgical alternatives. People are looking for less intrusive ways to repair scars and rejuvenate their skin instead of undergoing typical surgical procedures. As laser-based procedures for skin rejuvenation and scar correction become more common, there is an increasing demand for cutting-edge instruments and technology that can produce good outcomes with little risk or downtime.

 

Scar Treatment Market Trends

Key Trend Impact
Increased Application of Advanced Technologies Regarding its precision and effectiveness, technologies such as radiofrequency devices, laser therapy, and microneedling are becoming more and more popular. These techniques provide accurate scar tissue targeting and productive outcomes, thereby, contributing to elevated scar treatment market growth.
Preference for Non-Surgical Solutions The growing inclination towards minimally invasive procedures that have lower risks and downtime has led to an increase in demand for non-surgical scar treatment solutions. These therapies, such as microneedling and laser therapy, are appealing to people looking for non-surgical scar control that works well. They provide more accessibility to a broader spectrum of patients, reduced recovery periods, and fewer side effects. These therapies are made easier by advanced technologies, which also minimize invasiveness while producing effective results.
Rising Demand for Cosmetic Procedures The scar therapy treatment market size is expanding due to rising demand for cosmetic procedures brought on by social and cultural reasons. People are seeking scar treatments to improve their appearance and increase their self-esteem. This tendency is indicative of a larger cultural focus on self-improvement and aesthetics.
Customized Treatment Plans Healthcare professionals are adopting customized scar treatment regimens that consider requirements of each patient and take several elements including skin type, location, size, and scar type into account. This tailored method guarantees that treatment plans are formulated to maximize efficacy and patient satisfaction, indicating a change in scar management toward more patient-centred care.

 

Scar Treatment Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Scar Treatment Market Segmentation

Market Breakup by Scar Type

  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Contracture Scars
  • Stretch Marks

 

The market segmentation by treatment type includes atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. This market segment illustrates the different types of treatment types.

 

Market Breakup by Product

  • Topical Products
    • Creams
    • Gels
    • Silicon Sheets
    • Others
  • Laser Products
    • CO2 Laser
    • Pulse-dyed Laser
    • Others
  • Injectable
  • Others

 

Based on products, the scar treatment market is segmented into topical products, laser products, injectables, and others. Topical products include creams, gels, silicone sheets, and other formulations. Laser products comprise CO2 lasers, pulse-dyed lasers, and other laser devices. Injectable treatments are also offered for scar management. These segments reflect the diverse range of scar treatment options available, catering to varying patient needs and preferences. From non-invasive topical solutions to advanced laser therapies and injectable treatments, the market offers a comprehensive array of products aimed at reducing the appearance of scars and improving skin texture, ensuring a tailored approach to scar management.

 

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

 

End-users of scar treatment include hospitals, and ambulatory surgical centers, among others. These healthcare facilities provide access to treatment to diverse patient populations and clinical needs.

 

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
  • Japan
  • India

 

Based on regions, the market is divided into United States, EU-4 (Germany, France, Italy, and Spain) and the United Kingdom, along with Japan, and India. These areas reflect diverse healthcare environments and consumer preferences across various geographic areas. United States with a robust healthcare infrastructure is expected to lead the market share in the forecast period, while India and Japan are likely to witness expedited market growth.

 

Scar Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Scar Treatment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Alliance Pharma PLC
  • Perrigo Company plc
  • Newmedical Technology Inc.
  • Sonoma Pharmaceuticals, Inc.
  • HRA Pharma
  • Boston Scientific Corporation
  • CCA Industries, Inc.
  • Avita Medical,Inc.
  • Smith & Nephew PLC
  • Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
  • Sientra, Inc.
  • Mölnlycke Health Care AB
  • Merz Pharma
  • POLYTECH Health & Aesthetics GmbH
  • CYNOSURE LUTRONIC

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Scar Type
  • Product
  • End User
  • Region
Breakup by Scar Type
  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Contracture Scars
  • Stretch Marks
Breakup by Product
  • Topical Products
  • Laser Products 
  • Injectable
  • Others
Breakup by End User
  • Hospitals 
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • United States
  • EU-4 and the United Kingdom
  • Japan
  • India
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Alliance Pharma PLC
  • Perrigo Company plc
  • Newmedical Technology Inc.
  • Sonoma Pharmaceuticals, Inc.
  • HRA Pharma
  • Boston Scientific Corporation
  • CCA Industries, Inc.
  • Avita Medical,Inc. 
  • Smith & Nephew PLC
  • Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
  • Sientra, Inc.
  • Mölnlycke Health Care AB
  • Merz Pharma
  • POLYTECH Health & Aesthetics GmbH
  • CYNOSURE LUTRONIC

 

Key Queries Solved in the Scar Treatment Market Report 

  • How is the market landscape expected to evolve in the forecast period? 
  • What future trends can be anticipated in the market?
  • What will be the effect of each driver, challenge, and opportunity on the market? 
  • Which regional market is expected to experience expedited growth during the forecast period? 
  • Which production type will lead the market growth? 
  • Which end user is expected to dominate the respective market segment? 
  • What are the key research initiatives expected to boost the market value during the forecast period? 
  • Which treatment type is poised to make the highest impact on the Scar treatment market growth? 
  • What are the market shares, strategies, and product portfolios of the leading players in the market?
  • How is the regulatory landscape shaping the market?
  • What are the market dynamics, trends, and growth prospects in the key regional markets?
  • How is technology innovation impacting the development of scar treatment?
  • What are the investment opportunities and potential risks associated with the market?

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3     Scar Treatment Market Overview – 8 Major Markets

    3.1     Scar Treatment Market Historical Value (2017-2023) 
    3.2     Scar Treatment Market Forecast Value (2024-2032) 
4    Scar Overview 
    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Scar Pathway 
5    Patient Profile
    5.1    Patient Profile Overview
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Scar Type Success Rate
6    Scar Epidemiology Scenario and Forecast – 8 Major Markets
    6.1    8MM Epidemiology Scenario Overview (2017-2032)
    6.2    United States Scar Epidemiology Scenario and Forecast (2017-2032)
    6.3    EU-4 and United Kingdom Scar Epidemiology Scenario and Forecast (2017-2032)
        6.3.1    Germany Scar Epidemiology Scenario and Forecast (2017-2032)
        6.3.2    France Scar Epidemiology Scenario and Forecast (2017-2032)
        6.3.3    Italy Scar Epidemiology Scenario and Forecast (2017-2032)
        6.3.4    Spain Scar Epidemiology Scenario and Forecast (2017-2032)
        6.3.5    United Kingdom Scar Epidemiology Scenario and Forecast (2017-2032)
    6.4    Japan Scar Epidemiology Scenario and Forecast (2017-2032) 
    6.5    India Scar Epidemiology Scenario and Forecast (2017-2032)
7     Scar Treatment Market Landscape – 8 Major Markets 
    7.1    Scar Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Scar Treatment: Product Landscape
        7.2.1    Analysis by Scar Type
        7.2.2    Analysis by Product Type 
        7.2.3    Analysis by End User
8    Scar Challenges and Unmet Needs
    8.1    Scar Type Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Scar Treatment
10     Scar Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11     Scar Treatment Market Segmentation (2017-2032) - 8 Major Markets 
    11.1     Scar Treatment Market (2017-2032) by Scar Type
        11.1.1    Market Overview
        11.1.2    Atrophic Scars
        11.1.3    Hypertrophic and Keloid Scars
        11.1.4    Contracture Scars
        11.1.5    Stretch Marks
    11.2      Scar Treatment Market (2017-2032) by Product
        11.2.1    Market Overview
        11.2.2    Topical Products
            11.2.2.1    Creams
            11.2.2.2    Gels
            11.2.2.3    Silicon Sheets
            11.2.2.4    Others
        11.2.3    Laser Products 
            11.2.3.1    CO2 Laser
            11.2.3.2    Pulse-dyed Laser
            11.2.3.3    Others
        11.2.4    Injectable
        11.2.5    Others
    11.3     Scar Treatment Market (2017-2032) by End User
        11.3.1    Hospitals 
        11.3.2    Ambulatory Surgical Centers
        11.3.3    Others    
    11.4     Scar Treatment Market (2017-2032) by Region
        11.4.1    Market Overview
        11.4.2    United States
        11.4.3    EU-4 and the United Kingdom
            11.4.3.1    Germany
            11.4.3.2    France
            11.4.3.3    Italy
            11.4.3.4    Spain
            11.4.3.5    United Kingdom
        11.4.4    Japan
        11.4.5    India
12    United States  Scar Treatment Market (2017-2032)
    12.1    United States Scar Treatment Market Historical Value (2017-2023) 
    12.2    United States Scar Treatment Market Forecast Value (2024-2032)
    12.3    United States Scar Treatment Market (2017-2032) by Scar Type
        12.3.1    Market Overview
        12.3.2    Atrophic Scars
        12.3.3    Hypertrophic and Keloid Scars
        12.3.4    Contracture Scars
        12.3.5    Stretch Marks
    12.4    United States Scar Treatment Market (2017-2032) by Product
        12.4.1    Market Overview
        12.4.2    Topical Products
            12.4.2.1    Creams
            12.4.2.2    Gels
            12.4.2.3    Silicon Sheets
            12.4.2.4    Others
        12.4.3    Laser Products 
            12.4.3.1    CO2 Laser
            12.4.3.2    Pulse-dyed Laser
            12.4.3.3    Others
        12.4.4    Injectable
        12.4.5    Others
13    EU-4 and United Kingdom Scar Treatment Market (2017-2032)
    13.1    EU-4 and United Kingdom Scar Treatment Market Historical Value (2017-2023) 
    13.2    EU-4 and United Kingdom Scar Treatment Market Forecast Value (2024-2032)
    13.3    EU-4 and United Kingdom Scar Treatment Market (2017-2032) by Scar Type
        13.3.1    Market Overview
        13.3.2    Atrophic Scars
        13.3.3    Hypertrophic and Keloid Scars
        13.3.4    Contracture Scars
        13.3.5    Stretch Marks
    13.4    EU-4 and United Kingdom Scar Treatment Market (2017-2032) by Product
        13.4.1    Market Overview
        13.4.2    Topical Products
            13.4.2.1    Creams
            13.4.2.2    Gels
            13.4.2.3    Silicon Sheets
            13.4.2.4    Others
        13.4.3    Laser Products 
            13.4.3.1    CO2 Laser
            13.4.3.2    Pulse-dyed Laser
            13.4.3.3    Others
        13.4.4    Injectable
        13.4.5    Others
14    Japan Scar Treatment Market
    14.1    Japan Scar Treatment Market Historical Value (2017-2023) 
    14.2    Japan Scar Treatment Market Forecast Value (2024-2032)
    14.3    Japan Scar Treatment Market (2017-2032) by Scar Type
        14.3.1    Market Overview
        14.3.2    Atrophic Scars
        14.3.3    Hypertrophic and Keloid Scars
        14.3.4    Contracture Scars
        14.3.5    Stretch Marks
    14.4     Japan Scar Treatment Market (2017-2032) by Product
        14.4.1    Market Overview
        14.4.2    Topical Products
            14.4.2.1    Creams
            14.4.2.2    Gels
            14.4.2.3    Silicon Sheets
            14.4.2.4    Others
        14.4.3    Laser Products 
            14.4.3.1    CO2 Laser
            14.4.3.2    Pulse-dyed Laser
            14.4.3.3    Others
        14.4.4    Injectable
        14.4.5    Others
15    India Scar Treatment Market
    15.1    India Scar Treatment Market (2017-2032) Historical Value (2017-2023) 
    15.2    India Scar Treatment Market (2017-2032) Forecast Value (2024-2032)
    15.3    India Scar Treatment Market (2017-2032) by Scar Type
        15.3.1    Market Overview
        15.3.2    Atrophic Scars
        15.3.3    Hypertrophic and Keloid Scars
        15.3.4    Contracture Scars
        15.3.5    Stretch Marks
    15.4    India Scar Treatment Market (2017-2032) by Product
        15.4.1    Market Overview
        15.4.2    Topical Products
            15.4.2.1    Creams
            15.4.2.2    Gels
            15.4.2.3    Silicon Sheets
            15.4.2.4    Others
        15.4.3    Laser Products 
            15.4.3.1    CO2 Laser
            15.4.3.2    Pulse-dyed Laser
            15.4.3.3    Others
        15.4.4    Injectable
        15.4.5    Others
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    Japan PMDA 
        16.1.4    India CDSCO
        16.1.5    Others
17    Patent Analysis
    17.1    Analysis by Drug Type of Patent
    17.2    Analysis by Publication Year
    17.3    Analysis by Issuing Authority
    17.4    Analysis by Patent Age
    17.5    Analysis by CPC Analysis
    17.6    Analysis by Patent Valuation 
    17.7    Analysis by Key Players
18    Grants Analysis
    18.1    Analysis by Year
    18.2    Analysis by Amount Awarded
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Grant Application
    18.5    Analysis by Funding Institute
    18.6    Analysis by NIH Departments
    18.7    Analysis by Recipient Organization 
19    Clinical Trials Analysis
    19.1     Analysis by Trial Registration Year
    19.2    Analysis by Trial Status
    19.3    Analysis by Trial Phase
    19.4    Analysis by Therapeutic Area
    19.5    Analysis by Geography
20    Funding and Investment Analysis
    20.1    Analysis by Funding Instances
    20.2    Analysis by Drug Type of Funding
    20.3    Analysis by Funding Amount
    20.4    Analysis by Leading Players
    20.5    Analysis by Leading Investors
    20.6    Analysis by Geography
21    Partnership and Collaborations Analysis
    21.1    Analysis by Partnership Instances
    21.2    Analysis by Drug Type of Partnership
    21.3    Analysis by Leading Players
    21.4    Analysis by Geography
22    Supplier  Landscape
    22.1    Alliance Pharma PLC
        22.1.1    Financial Analysis 
        22.1.2    Product Portfolio 
        22.1.3    Demographic Reach and Achievements 
        22.1.4    Mergers and Acquisitions 
        22.1.5    Certifications 
    22.2    Perrigo Company plc
        22.2.1    Financial Analysis 
        22.2.2    Product Portfolio 
        22.2.3    Demographic Reach and Achievements 
        22.2.4    Mergers and Acquisitions 
        22.2.5    Certifications 
    22.3    Newmedical Technology Inc.
        22.3.1    Financial Analysis
        22.3.2    Product Portfolio
        22.3.3    Demographic Reach and Achievements
        22.3.4    Mergers and Acquisitions
        22.3.5    Certifications
    22.4     Sonoma Pharmaceuticals, Inc.
        22.4.1     Financial Analysis
        22.4.2    Product Portfolio
        22.4.3    Demographic Reach and Achievements
        22.4.4    Mergers and Acquisitions
        22.4.5    Certifications
    22.5    HRA Pharma
        22.5.1    Financial Analysis
        22.5.2    Product Portfolio
        22.5.3    Demographic Reach and Achievements
        22.5.4    Mergers and Acquisitions
        22.5.5    Certifications
    22.6    Boston Scientific Corporation
        22.6.1    Financial Analysis
        22.6.2    Product Portfolio
        22.6.3    Demographic Reach and Achievements
        22.6.4    Mergers and Acquisitions
        22.6.5    Certifications
    22.7      CCA Industries, Inc.
        22.7.1    Financial Analysis
        22.7.2    Product Portfolio
        22.7.3    Demographic Reach and Achievements
        22.7.4    Mergers and Acquisitions
        22.7.5    Certifications
    22.8    Avita Medical,Inc. 
        22.8.1    Financial Analysis
        22.8.2    Product Portfolio
        22.8.3    Demographic Reach and Achievements
        22.8.4    Mergers and Acquisitions
        22.8.5    Certifications
    22.9    Smith & Nephew PLC
        22.9.1    Financial Analysis
        22.9.2    Product Portfolio
        22.9.3    Demographic Reach and Achievements
        22.9.4    Mergers and Acquisitions
        22.9.5    Certifications
    22.10    Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
        22.10.1    Financial Analysis
        22.10.2    Product Portfolio
        22.10.3    Demographic Reach and Achievements
        22.10.4    Mergers and Acquisitions
        22.10.5    Certifications 
    22.11    Sientra, Inc.
        22.11.1    Financial Analysis
        22.11.2    Product Portfolio
        22.11.3    Demographic Reach and Achievements
        22.11.4    Mergers and Acquisitions
        22.11.5    Certifications                     
    22.12    Mölnlycke Health Care AB
        22.12.1    Financial Analysis
        22.12.2    Product Portfolio
        22.12.3    Demographic Reach and Achievements
        22.12.4    Mergers and Acquisitions
        22.12.5    Certifications                 
    22.13    Merz Pharma
        22.13.1    Financial Analysis
        22.13.2    Product Portfolio
        22.13.3    Demographic Reach and Achievements
        22.13.4    Mergers and Acquisitions
        22.13.5    Certifications
    22.14    POLYTECH Health & Aesthetics GmbH
        22.14.1    Financial Analysis
        22.14.2    Product Portfolio
        22.14.3    Demographic Reach and Achievements
        22.14.4    Mergers and Acquisitions
        22.14.5    Certifications
    22.15    CYNOSURE LUTRONIC
        22.15.1    Financial Analysis
        22.15.2    Product Portfolio
        22.15.3    Demographic Reach and Achievements
        22.15.4    Mergers and Acquisitions
        22.15.5    Certifications       
23    Scar Treatment Market - Distribution Model (Additional Insight)
    23.1    Overview 
    23.2    Potential Distributors 
    23.3    Key Parameters for Distribution Partner Assessment 
24    Key Opinion Leaders (KOL) Insights (Additional Insight)
25    Company Competitiveness Analysis (Additional Insight)

    25.1    Very Small Companies
    25.2    Small Companies
    25.3    Mid-Sized Companies
    25.4    Large Companies
    25.5    Very Large Companies
26    Payment Methods (Additional Insight)
    26.1    Government Funded
    26.2    Private Insurance
    26.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Key Questions Answered in the Report

The market attained a value of about USD 20.32 billion in 2023 driven by the rising prevalence of demand for cosmetic procedures across the 8 major markets.

The market is anticipated to grow at a CAGR of 11% during the forecast period of 2024-2032, likely to reach a market value of USD 51.39 billion by 2032. 

Growing demands for personalized treatment plans as well as rising disposable incomes are fuelling the demand for the market.

The growing preference for non-surgical scar treatment options is one significant market trends. Methods that reduce scars precisely and effectively, such microneedling and laser therapy, are gaining wide popularity amongst the consumers.

It includes atrophic scars, hypertrophic and keloid scars, contracture scars and stretch marks.

Based on product type, the market for scar treatment includes topical products, laser products, and injectables among others. Topical products include silicone sheets, gels, lotions, and other compositions.CO2 lasers, pulse-dyed lasers, and other laser devices are typical laser products. 

End-users of scar treatment include hospitals, and ambulatory surgical centers, among others.

The major regions of the market include the United States, EU-4 (Germany, France, Italy, and Spain), the United Kingdom, Japan, and India.  

Key players involved in the market are Alliance Pharma PLC, Perrigo Company plc, Newmedical Technology Inc., Sonoma Pharmaceuticals, Inc., HRA Pharma, Boston Scientific Corporation, CCA Industries, Inc., Avita Medical, Inc., Smith & Nephew PLC, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Sientra, Inc., Molnlycke Health Care AB, Merz Pharma, POLYTECH Health & Aesthetics GmbH and CYNOSURE LUTRONIC

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER